Review
Open access
Oct 2026
The burden of genitourinary syndrome of menopause and barriers to treatment in a safety-net breast cancer population.
459 Background: Women receiving pharmacologic treatment for breast cancer (BC) often suffer from genitourinary syndrome of menopause (GSM). Many studies have demonstrated the safety of vaginal estrogen in this population with no evidence of higher risk of BC-associated mortality. However, current literature ref...
Ananya Murthy, Edward J. Padilla, A. Lopez et al.
· JCO Oncology Practice · 0 citations